MedTrace Logo

An Observational Study of Cholesterol in Coronary Arteries

NCT00831116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2067

Last updated 2017-06-09

No results posted yet for this study

Summary

In April 2008, a coronary catheter based imaging system, LipiScan, was cleared by the FDA for use in detecting lipid core containing containing plaques of interest (LCP). These plaques are rich in cholesterol. The way that cholesterol and other lipids deposit with the coronary artery is unique to each patient. This study is an organized attempt to observe the LCP and the variety of ways that it presents in patients as detected by this recently approved device. This information will be used for physician training and to observe the behavior of the LCP in response to no therapy and currently approved therapies. The purpose of this project is further medical knowledge of the LCP and its treatment.

Conditions

Interventions

DEVICE

Intravascular Near Infrared Spectroscopy

Intravascular imaging with a catheter based spectroscopy system.

Sponsors & Collaborators

  • Infraredx

    lead INDUSTRY

Principal Investigators

  • Giora Weisz, MD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2016-02-29
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831116 on ClinicalTrials.gov